PCR analysis further demonstrated that the expression levels of ITGA4, ITPR2, ADGRE2, ANKRD28, KDM5B, and CDK6 in NK-AML (M4/M5) were significantly higher than those in normal controls, suggesting that these genes may be possible biomarkers of NK-AML. This evidence concerns the gene ITGA4 and acute myeloid leukemia.